European regulator recommends Pfizer's Omicron booster for children
Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.
The Omicron-tailored vaccine is already authorised by the European Commission for individuals aged 12 years and above. The updated bivalent booster shot targets the original coronavirus strain as well as the BA.4 and BA.5 sub-variants of Omicron.
In October, European Medical Agency backed authorization of Moderna Inc's COVID-19 tailored booster shots for 12 and above to further vaccination campaigns in the region.
ALSO READ
-
Colombia Bets on Vaccine Manufacturing to Build Health Security and Cut Import Dependence
-
Colombia Gets €15 Million Boost to Build Vaccine Capacity and Cut Import Dependence
-
France Plans Housing Hub to Unlock European Funding and Technical Expertise
-
EU and EIB Launch Investor Pact to Help European Tech Firms Compete on Global Stage
-
EIB- UNDP €15 Million Partnership Backs Recovery for Communities in Crisis
Google News